ATG2A did not show a significant increase in EBV-negative NPC compared to healthy controls (p = 0.44), and expression levels were slightly higher in EBV-positive NPC compared to EBV-negative NPC, although not significant (p = 0.22) (Figure 1). Here, ATG2A is linked to nasopharyngeal carcinoma.